Duloxetine in the treatment of major depressive disorder.
about
Treatment-emergent sexual dysfunction with SSRIs and duloxetine: effectiveness and functional outcomes over a 6-month observational period.Vilazodone HCl (Viibryd): A Serotonin Partial Agonist and Reuptake Inhibitor For the Treatment of Major Depressive Disorder.Adverse reactions to duloxetine in depression.Acute and subacute effects of the selective serotonin-noradrenaline reuptake inhibitor duloxetine on cardiac hERG channels.Formulation and optimization of duloxetine hydrochloride buccal films: in vitro and in vivo evaluation.
P2860
Duloxetine in the treatment of major depressive disorder.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Duloxetine in the treatment of major depressive disorder.
@en
Duloxetine in the treatment of major depressive disorder.
@nl
type
label
Duloxetine in the treatment of major depressive disorder.
@en
Duloxetine in the treatment of major depressive disorder.
@nl
prefLabel
Duloxetine in the treatment of major depressive disorder.
@en
Duloxetine in the treatment of major depressive disorder.
@nl
P2860
P1476
Duloxetine in the treatment of major depressive disorder.
@en
P2093
David J Goldstein
P2860
P304
P356
10.2147/NEDT.2007.3.2.193
P407
P577
2007-04-01T00:00:00Z